Sex Differences in Adverse Liver and Nonliver Outcomes in Steatotic Liver Disease
Taotao Yan(First Affiliated Hospital of Xi'an Jiaotong University), Mindie H. Nguyen(Palo Alto University), Ramsey Cheung(VA Palo Alto Health Care System), Xinrong Zhang(Tianjin Medical University)
Cited by 11
Related Papers
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
|Hepatology|2021|91
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
|Gastroenterology|2025|72
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040
|JAMA Network Open|2024|68
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
|Hepatology|2022|54
Non-invasive tests of non-alcoholic fatty liver disease
|Chinese Medical Journal|2022|51